Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VE-1902
VE-1902
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
CP Wire
Thu, 06/14/18 - 09:48 am
Verseon
VE-1902
anticoagulants
Verseon to Initiate Ph I Study of New Class Anticoagulant with Reduced Bleeding Risk
Thu, 06/14/18 - 09:31 am
Verseon
VE-1902
anticoagulants